Study 110933: Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2018
At a glance
- Drugs Albiglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 23 Nov 2017 Status changed from active, no longer recruiting to completed.
- 31 Oct 2017 This trial has been discontinued in Germany (end date: 18 Oct 2017).
- 07 Aug 2017 Planned End Date changed from 19 Feb 2018 to 9 Oct 2018.